FNY Investment Advisers’s Acutus Medical Inc AFIB Stock Holding History

FNY Investment Advisers’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-400	Closed	–	–	783
2022 Q4	$0	Buy	+400	New	+$330	﹤0.01%	812

Other funds holding AFIB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

FNY Investment Advisers's AFIB Position: Q1 2023 in Review

FNY Investment Advisers sold out of Acutus Medical Inc (AFIB) in Q1 2023, closing a stake of 400 shares.

FNY Investment Advisers first reported a position in AFIB in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 38 funds tracked by Wall St. Rank hold AFIB as of Q1 2023.

FNY Investment Advisers reported no remaining Acutus Medical Inc position as of Q1 2023 after selling out during the quarter.
FNY Investment Advisers sold 400 Acutus Medical Inc shares in Q1 2023.
FNY Investment Advisers first reported a position in Acutus Medical Inc in Q4 2022 and held it in 1 quarter.
FNY Investment Advisers's Acutus Medical Inc position peaked at $0 in Q4 2022.
38 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.